as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (20.0%)
Weaknesses (2)
- •High debt-to-equity ratio (3.53)
- •Below-average fundamentals quality score (36/100)
Opportunities (1)
- •Strong 3-year revenue growth (20.5%)
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
11.2%
Net margin 2.74% × asset turnover 0.78x × equity multiplier 5.24x
Company Overview
Market Cap
₹7,707 Cr
P/E (TTM)
176.0
ROE
13.0%
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 28 Oct 2026. Not investment advice.
TopFund Analysis
Paras Healthcare Limited scores weakly on TopFund's composite fundamentals check, at 36/100. The strongest factor is Growth (100/100), while Financial Strength (0/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (20.0%); high debt-to-equity ratio (3.53); below-average fundamentals quality score (36/100). Strong 3-year revenue growth (20.5%).
TopFund Score — Fundamentals Quality
36/100 — WeakData confidence: 63/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Business Quality
From Screener.in
- −Company has low interest coverage ratio.
- −Company has a low return on equity of -3.55% over last 3 years.
- −Debtor days have increased from 65.4 to 79.4 days.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Source: BSE regulatory filings, via Screener.in.
Profit & Loss (Yearly)
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales + | 918 | 1,129 | 1,294 | 1,606 |
| Expenses + | 846 | 994 | 1,155 | 1,290 |
| Operating Profit | 71 | 135 | 139 | 316 |
| OPM % | 8.0% | 12.0% | 11.0% | 20.0% |
| Other Income + | 18 | 22 | 20 | 23 |
| Interest | 51 | 69 | 94 | 119 |
| Depreciation | 65 | 81 | 116 | 144 |
| Profit before tax | -27 | 7 | -50 | 76 |
| Tax % | 58.0% | 331.0% | 16.0% | 42.0% |
| Net Profit + | -43 | -15 | -58 | 44 |
| EPS in Rs | -4 | -2 | -6 | 4 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Reserves | 26 | 329 | 271 | 385 |
| Borrowings + | 756 | 548 | 728 | 1,394 |
| Other Liabilities + | 507 | 592 | 802 | 282 |
| Total Liabilities | 1,293 | 1,478 | 1,810 | 2,071 |
| Fixed Assets + | 780 | 988 | 1,173 | 1,211 |
| CWIP | 78 | 29 | 38 | 29 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets + | 435 | 461 | 599 | 832 |
| Total Assets | 1,293 | 1,478 | 1,810 | 2,071 |
| Equity Capital | 4 | 10 | 10 | 10 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 44 | 92 | 86 | 164 |
| Cash from Investing Activity + | -126 | -194 | -147 | -239 |
| Cash from Financing Activity + | 97 | 94 | 83 | 86 |
| Net Cash Flow | 15 | -8 | 22 | 10 |
| Free Cash Flow | -69 | -102 | -49 | -5 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 106 | 76 | 69 | 69 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Which Mutual Funds Hold Paras Healthcare Limited?
Frequently Asked Questions about Paras Healthcare Limited
Paras Healthcare Limited trades on the NSE (National Stock Exchange of India) under the symbol PARASHLTH.
Paras Healthcare Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 176.0.
Paras Healthcare Limited has a market capitalisation of ₹7,707 crore.
Paras Healthcare Limited has a TopFund Quality Score of 36/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Paras Healthcare Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.